Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Apoptosis”

539 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 539 results

Testing effectiveness (Phase 2)Study completedNCT00150982
What this trial is testing

Alefacept Mechanism of Action in Psoriasis

Who this might be right for
Psoriasis
University of Medicine and Dentistry of New Jersey 9
Testing effectiveness (Phase 2)Study completedNCT04361331
What this trial is testing

Two-cohort Study of Toripalimab(PD1)+Lenvatnib, or Gemox+Lenvatinib in Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma, Intrahepatic
Shanghai Zhongshan Hospital 61
Not applicableStudy completedNCT00156273
What this trial is testing

Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
University of Michigan Rogel Cancer Center 69
Large-scale testing (Phase 3)Study completedNCT02494583
What this trial is testing

Study of Pembrolizumab (MK-3475) as First-Line Monotherapy and Combination Therapy for Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-062/KEYNOTE-062)

Who this might be right for
Gastric Adenocarcinoma
Merck Sharp & Dohme LLC 763
Not applicableStudy completedNCT03728192
What this trial is testing

In-vitro Effect of Mangosteen Pericarp Extract on Cell Lines

Who this might be right for
Apoptosis
Meenakshi Ammal Dental College and Hospital 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT06483334
What this trial is testing

Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Plus Enfortumab Vedotin (EV) With and Without Pembrolizumab in Advanced Urothelial Carcinoma (MK-3475-04C/KEYMAKER-U04)

Who this might be right for
Metastatic Urothelial CarcinomaLocally Advanced Urothelial Carcinoma
Merck Sharp & Dohme LLC 38
Not applicableUnknownNCT04431505
What this trial is testing

Anaesthesia and Apoptosis

Who this might be right for
Apoptosis
Assiut University 20
Early research (Phase 1)Study completedNCT03111992
What this trial is testing

Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Novartis Pharmaceuticals 26
Not applicableStudy completedNCT05643599
What this trial is testing

The Relationship With Mad Honey Containing Grayanotoxin and Ovary Tissue

Who this might be right for
Ovary Disease
Manisa Celal Bayar University 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT04950075
What this trial is testing

Study of INBRX-109 in Conventional Chondrosarcoma

Who this might be right for
Conventional Chondrosarcoma
Inhibrx Biosciences, Inc 206
Large-scale testing (Phase 3)Study completedNCT03875092
What this trial is testing

Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407)-China Extension Study

Who this might be right for
Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 125
Early research (Phase 1)Study completedNCT00079300
What this trial is testing

Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer

Who this might be right for
Non-melanomatous Skin Cancer
National Naval Medical Center
Testing effectiveness (Phase 2)Study completedNCT00001422
What this trial is testing

A Controlled Trial of Intermittent Fludarabine for Psoriatic Arthritis

Who this might be right for
Arthritis, PsoriaticPsoriasis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 20
Testing effectiveness (Phase 2)UnknownNCT03263039
What this trial is testing

Biomarkers in Urothelial Cancer Patients Treated With Pembrolizumab

Who this might be right for
Transitional Cell Carcinoma of the BladderBiomarkers
Erasmus Medical Center 80
Not applicableUnknownNCT02385331
What this trial is testing

Molecular Mechanism of Neutrophil Necroptosis and Its Roles in RA Pathogenesis

Who this might be right for
Healthy
The Third Affiliated Hospital of Southern Medical University 30
Not applicableWithdrawnNCT00762801
What this trial is testing

Studies on the Expression and Functions of RLIP76 in Blood Samples of Healthy Human Subjects

Who this might be right for
Healthy
University of North Texas Health Science Center
Not applicableNot Yet RecruitingNCT07145437
What this trial is testing

Prostate Stereotactic Radiation and Radio-induced Lymphocyte Apoptosis for Predicting Late Toxicities in Prostate Cancer (PROSTERA)

Who this might be right for
Prostate Cancer
Clinique Sainte Clotilde 220
Testing effectiveness (Phase 2)UnknownNCT05281003
What this trial is testing

Pembrolizumab Plus Chemo in Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma (Eastern Cooperative Thoracic Oncology Projects 2004, ECTOP-2004)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 128
Not applicableUnknownNCT00197379
What this trial is testing

The Effect of 0.5% Roxithromycin Lotion for Androgenetic Alopecia

Who this might be right for
Alopecia
Hamamatsu University 20
Early research (Phase 1)Study completedNCT03003676
What this trial is testing

A Pilot Study of Sequential ONCOS-102, an Engineered Oncolytic Adenovirus Expressing GMCSF, and Pembrolizumab in Patients With Advanced or Unresectable Melanoma Progressing After Programmed Cell Death Protein 1 (PD1) Blockade

Who this might be right for
Advanced or Unresectable Melanoma Progressing After PD1 Blockade
Targovax Oy 21
Next Page